Patients sound off and they’re angry!

KEY TAKEAWAY: I was invited to attend a focus group panel on health care in Weston, Florida and was not prepared for the anger and frustration I heard from the range of people of all ages, demographics and backgrounds.  It’s clear our health care system is very broken and that “empowered patients” is more of a buzzword than reality. Continue reading

Remember when pharma was about medicines, not earnings-per-share?

KEY TAKEAWAY: Bruce Grant, an industry veteran recently said on LinkedIn “shareholder value” and value to society (or even customers) are not the same thing. And when they are in direct opposition, as in “activist investor”-driven pharma M&A — which to date has generated billions in fees for investment bankers and capital gains for the aforementioned “activist investors”while consistently destroying the long-term value of the companies involved — it should be called out for the kind of antisocial parasitism that it is”. Continue reading

Marketing jobs (and talent) leaving pharma

KEY TAKEAWAY: In 2015, SCORR’s Health Sciences Marketing Trends Survey Report found 60 percent of companies have a marketing team consisting of five or fewer professionals; however, in 2016 that number jumped to 79 percent. Is this an anomaly or is this the start of a new trend in the health sciences industry? If this is the new trend, what could be the cause? No, it’s not new, and yes, it’s going to continue. Continue reading